Bausch Health Companies BHC
NYSE BHC
$6.82 -0.07 (-1.09%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026)

Bausch Health Companies (BHC) posted Income from Non-Controlling Interests of $2.0 million for Q2 2026, up 125.0% sequentially from -$8.0 million in Q1 2026, and up 110.0% YoY from $952381.0 in Q2 2025.

Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends

Bausch Health Companies has reported Income from Non-Controlling Interests for 14 years, with the latest figure at $2.0 million in Q2 2026.

  • Quarterly Income from Non-Controlling Interests rose 110.0% year-over-year to $2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.0 million (up 110.0% YoY) and the FY2025 annual result came in at -$37.0 million, down 42.31% from the prior year.
  • Income from Non-Controlling Interests rose to $2.0 million in Q2 2026 per BHC's latest filing, from -$8.0 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $9.0 million in Q4 2025 and troughed at -$28.0 million in Q1 2025.
  • A 5-year average of -$4.4 million and a median of -$4.0 million in 2023 frame the typical range for Income from Non-Controlling Interests.
  • The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests jumped 200.0% in 2022, then slumped 1200.0% in 2024.
  • Over 5 years, Income from Non-Controlling Interests stood at $4.0 million in 2022, then slumped by 300.0% to -$8.0 million in 2023, then jumped by 162.5% to $5.0 million in 2024, then soared by 80.0% to $9.0 million in 2025, then tumbled by 77.78% to $2.0 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $2.0 million, -$8.0 million, and $9.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Bausch Health Companies 2.56 Bn 725.13 Mn 2.10 Bn 2.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Mn
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 -20.00 Mn
Mar 31, 2025 -28.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 -7.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -13.00 Mn
Dec 31, 2023 -8.00 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 -8.00 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 2.00 Mn